USPHS-CDC news.
D002487:Centers for Disease Control and Prevention, U.S.; D056486:Chemical and Drug Induced Liver Injury; D003142:Communication; D006801:Humans; D011718:Pyrazinamide / Q000008:administration & dosage / Q000009:adverse effects; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D014376:Tuberculosis / Q000188:drug therapy / Q000517:prevention & control; D014481:United States; D014492:United States Public Health Service
D011718:Pyrazinamide; D012293:Rifampin